Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Total
BALANCE at Dec. 31, 2021 $ 31 $ 1,823,344 $ (568,611) $ (6,414) $ 1,248,350
BALANCE (in shares) at Dec. 31, 2021 311,473,950        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of Common Stock options   900     900
Exercise of Common Stock options (in shares) 786,693        
Vesting of restricted Common Stock (in shares) 84,384        
Vesting of restricted share units (in shares) 520,265        
Repurchase of shares for employee tax withholdings   (158)     (158)
Repurchase of shares for employee tax withholdings (in shares) (39,720)        
Stock-based compensation expense   9,912     9,912
Net loss     (69,944)   (69,944)
Other comprehensive income (loss)       (11,035) (11,035)
BALANCE at Mar. 31, 2022 $ 31 1,833,998 (638,555) (17,449) 1,178,025
BALANCE (in shares) at Mar. 31, 2022 312,825,572        
BALANCE at Dec. 31, 2022 $ 32 1,874,792 (1,308,954) (38,368) 527,502
BALANCE (in shares) at Dec. 31, 2022 318,133,434        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of Common Stock options   597     597
Exercise of Common Stock options (in shares) 495,876        
Vesting of restricted Common Stock (in shares) 25,375        
Vesting of restricted share units (in shares) 1,808,422        
Repurchase of shares for employee tax withholdings   (99)     (99)
Repurchase of shares for employee tax withholdings (in shares) (61,718)        
Stock-based compensation expense   8,474     8,474
Net loss     (52,642)   (52,642)
Other comprehensive income (loss)       1,738 1,738
BALANCE at Mar. 31, 2023 $ 32 $ 1,883,764 $ (1,361,596) $ (36,630) $ 485,570
BALANCE (in shares) at Mar. 31, 2023 320,401,389